Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Amines. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110407737B reveals a streamlined Grignard route for cyproheptadine hydrochloride, offering higher purity and safer manufacturing for global supply chains.
Patent CN1309121A details efficient chiral resolution of antihistamine intermediates using DPTTA, offering high purity and scalable manufacturing for global supply chains.
Patent CN101208292A details a safe, high-yield process for converting hydroxamic acids to amines using alkylphosphonic anhydrides, offering significant cost reduction in amine manufacturing.
Patent CN102134176A introduces a ligand-free zinc complex method for aromatic C-N bond formation, offering cost-effective and scalable solutions for pharmaceutical intermediates.
Patent CN114591185B introduces a green iridium-catalyzed method for amino alcohol synthesis using ethylene glycol, offering high selectivity and supply chain advantages.
Patent CN102675283A reveals a novel acid-catalyzed condensation route for Bepotastine intermediates, offering superior chiral purity and yield compared to traditional base-mediated methods.
Novel SmI2-catalyzed reductive deuteration of nitriles offers high yield and regioselectivity. A cost-effective supply chain solution for deuterated drug manufacturing.
Patent CN107827756A reveals catalyst reducing N-methyl impurities. Enhances supply chain reliability and cost efficiency for global buyers.
Patent CN106866425A reveals metal-free bromination. Enhances supply chain reliability and cost reduction in pharma intermediates manufacturing.
Patent CN110551771B details a green enzymatic route for chiral 3-amino-1-butanol. Discover cost-effective, high-purity pharmaceutical intermediate manufacturing solutions.
Patent CN103864624A reveals a solvent-free, metal-free N-alkylation method. Discover cost-effective manufacturing and high-purity supply chain solutions for pharmaceutical intermediates.
Patent CN113061091B reveals a green Cu-Co/Al2O3 catalytic route for N-alkylation. Offers cost reduction and high purity for pharmaceutical intermediates manufacturing.
Patent CN103539596A introduces a green catalytic method for amine synthesis. This technology offers significant supply chain stability and cost reduction benefits for global pharmaceutical manufacturing partners.
Patent CN103539596A enables safe formic acid hydrogen transfer for amine synthesis. Offers cost reduction and supply chain reliability for global chemical manufacturers.
Patent CN112552215A details a nickel-catalyzed dehydrogenative coupling for allylamine derivatives, offering cost reduction in pharmaceutical intermediate manufacturing via atom-economical pathways.
Patent CN115448841A reveals a cost-effective silver-catalyzed method for synthesizing primary amines using ammonia water, offering significant advantages for pharmaceutical intermediate manufacturing.
Patent CN105017150A details a palladium-catalyzed asymmetric hydrogenation method for high-purity chiral exocyclic amines, offering significant supply chain and cost advantages.
Patent CN100560561C discloses a high stereoselective route to chiral alpha-difluoromethylamines using sulfone reagents, offering superior purity and scalability for API manufacturing.
Novel crystallization method ensures 99.9% purity for Bilastine. Reduces impurities and enhances stability for reliable pharmaceutical supply chains.
Patent CN113789527A reveals a metal-free electrochemical route for aromatic amines. Discover cost-effective, green manufacturing for high-purity pharmaceutical intermediates.